Diabetes Medicine Franchise in Ahmedabad

Anti-diabetic Tablet Supplier in Mumbai

Type 2 Diabetes Medicine Distributor in Delhi

Oral Hypoglycemic Tablet Manufacturer in Bangalore

Diabetes Care Tablet Stockist in Hyderabad
Diabetology Medicine Exporter in Chandigarh

Home/Products /dapagliflozin-10mg-metformin-500mg-sr-vildagliptin-100mg-tablets

Dapoflit VM Tablet

Composition : Dapagliflozin (10mg) + Metformin (500mg) + Vildagliptin (100mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Dapagliflozin 10mg + Metformin 500mg SR + Vildagliptin 100mg Tablet is a triple-combination oral anti-diabetic formulation used for the treatment of type 2 diabetes mellitus in patients requiring improved glycemic control.

This combination works through complementary mechanisms—dapagliflozin reduces glucose reabsorption via the kidneys, metformin improves insulin sensitivity and reduces hepatic glucose production, while vildagliptin enhances incretin activity to regulate insulin secretion.

Clinically, it is prescribed for patients with uncontrolled blood glucose levels, helping manage fasting and postprandial glucose while reducing the risk of long-term diabetic complications.

With rising diabetes prevalence and strong demand for fixed-dose combinations, this formulation supports consistent prescriptions, enhances portfolio strength, and helps attract long-term associations through effective, comprehensive glucose management solutions.

Read More

About the Product

Dapagliflozin 10mg + Metformin 500mg SR + Vildagliptin 100mg Tablet is a triple-combination oral anti-diabetic formulation used for the treatment of type 2 diabetes mellitus in patients requiring improved glycemic control.

This combination works through complementary mechanisms—dapagliflozin reduces glucose reabsorption via the kidneys, metformin improves insulin sensitivity and reduces hepatic glucose production, while vildagliptin enhances incretin activity to regulate insulin secretion.

Clinically, it is prescribed for patients with uncontrolled blood glucose levels, helping manage fasting and postprandial glucose while reducing the risk of long-term diabetic complications.

With rising diabetes prevalence and strong demand for fixed-dose combinations, this formulation supports consistent prescriptions, enhances portfolio strength, and helps attract long-term associations through effective, comprehensive glucose management solutions.

Common side effects may include nausea, diarrhea, abdominal discomfort, headache, urinary tract infections, or genital infections. Rarely, hypoglycemia may occur when used with other antidiabetic agents.

Dapoflit VM Tablet is indicated for the management of type 2 diabetes mellitus in patients whose blood glucose levels are not adequately controlled with diet and exercise alone. It helps achieve better fasting and postprandial glycemic control as advised by a physician.

Use this medicine strictly under medical supervision. Follow the prescribed dosage and timing. Monitor blood glucose levels regularly. Caution is advised in patients with renal impairment, dehydration, or a history of recurrent infections.

Store below 25°C in a cool, dry place. Protect from moisture. Keep out of reach of children.

Get in Touch